Compound 33c (ADTL-SA1215) may be the earliest SIRT3-specific small molecule activator in the current research field, which can regulate the SIRT3-driven autophagy/mitophagy signaling pathways to inhibit the proliferation and invasion of human breast cancer cells (111). The gene discussed is SIRT3; the disease is breast cancer.